Biphasic insulin aspart 70/30 three times a day in older patients with type 2 diabetes not achieving optimal glycemic control on a twice-daily regimen: A retrospective case series analysis from clinical practice

Advances in Therapy

Volumn 24, Issue 6, 2007, Pages 1348-1356

  Tibaldi, Joseph T ^a,b  

^a FLUSHING HOSPITAL MEDICAL CENTER   (United States)

^b Queens Diabetes and Endocrinology   (United States)

Author keywords

BIAsp 30; Dosing; HbA 1c; Hypoglycemia; Premixed insulin analog

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; BIPHASIC INSULIN; HEMOGLOBIN A1C; INSULIN ASPART; METFORMIN; DRUG DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN, ASP(B28)-; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; EVENING DOSAGE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; AGE; DRUG ADMINISTRATION; FEMALE; GLUCOSE BLOOD LEVEL; MALE; MIDDLE AGED; RETROSPECTIVE STUDY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 41749096171     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02877782     Document Type: Article

References (28)